MA27763A1 - Composes n-formyl-hydroxylamine cristallins - Google Patents
Composes n-formyl-hydroxylamine cristallinsInfo
- Publication number
- MA27763A1 MA27763A1 MA28547A MA28547A MA27763A1 MA 27763 A1 MA27763 A1 MA 27763A1 MA 28547 A MA28547 A MA 28547A MA 28547 A MA28547 A MA 28547A MA 27763 A1 MA27763 A1 MA 27763A1
- Authority
- MA
- Morocco
- Prior art keywords
- formyl
- crystalline
- hydroxylamine compounds
- compounds
- 7alkanes
- Prior art date
Links
- KDGKTJGPFXIBEB-UHFFFAOYSA-N n-hydroxyformamide Chemical class ONC=O KDGKTJGPFXIBEB-UHFFFAOYSA-N 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- -1 N-hydroxyformamido Chemical group 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45972603P | 2003-04-02 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27763A1 true MA27763A1 (fr) | 2006-02-01 |
Family
ID=33131903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28547A MA27763A1 (fr) | 2003-04-02 | 2005-10-11 | Composes n-formyl-hydroxylamine cristallins |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070135353A1 (https=) |
| EP (1) | EP1613305A1 (https=) |
| JP (1) | JP2006522054A (https=) |
| KR (1) | KR20060002915A (https=) |
| CN (1) | CN1764450A (https=) |
| AR (1) | AR043804A1 (https=) |
| AU (1) | AU2004226815B2 (https=) |
| BR (1) | BRPI0409009A (https=) |
| CA (1) | CA2520682A1 (https=) |
| CL (1) | CL2004000705A1 (https=) |
| CO (1) | CO5630028A2 (https=) |
| EC (1) | ECSP056043A (https=) |
| IS (1) | IS8093A (https=) |
| MA (1) | MA27763A1 (https=) |
| MX (1) | MXPA05010610A (https=) |
| MY (1) | MY136854A (https=) |
| NO (1) | NO20055097L (https=) |
| NZ (1) | NZ542432A (https=) |
| PE (1) | PE20050392A1 (https=) |
| RU (1) | RU2005133660A (https=) |
| SG (1) | SG166681A1 (https=) |
| TN (1) | TNSN05248A1 (https=) |
| TW (1) | TW200427458A (https=) |
| WO (1) | WO2004087133A1 (https=) |
| ZA (1) | ZA200507179B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1406893B1 (en) | 2001-06-15 | 2007-04-18 | Vicuron Pharmaceuticals, Inc. | Pyrrolidine bicyclic compounds |
| ATE417826T1 (de) | 2002-09-19 | 2009-01-15 | Novartis Pharma Gmbh | Verfahren zur herstellung von zwischenprodukten |
| MXPA05008842A (es) | 2003-02-21 | 2005-10-05 | Novartis Ag | Proceso quimico. |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
| JP7001898B2 (ja) * | 2016-05-11 | 2022-01-20 | グアンドン・ヘボ・ファーマシューティカル・カンパニー・リミテッド | スピロ３員環、スピロ５員環系ペプチドデホルミラーゼ阻害剤および抗菌と抗腫瘍におけるその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| DK1052984T3 (da) * | 1998-02-07 | 2004-09-20 | Vernalis Oxford Ltd | Antibakterielle midler |
| AR036053A1 (es) * | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
-
2004
- 2004-03-29 TW TW093108548A patent/TW200427458A/zh unknown
- 2004-03-31 AR ARP040101079A patent/AR043804A1/es not_active Application Discontinuation
- 2004-03-31 PE PE2004000339A patent/PE20050392A1/es not_active Application Discontinuation
- 2004-04-01 MX MXPA05010610A patent/MXPA05010610A/es unknown
- 2004-04-01 CN CNA2004800078725A patent/CN1764450A/zh active Pending
- 2004-04-01 AU AU2004226815A patent/AU2004226815B2/en not_active Ceased
- 2004-04-01 SG SG200801365-8A patent/SG166681A1/en unknown
- 2004-04-01 MY MYPI20041200A patent/MY136854A/en unknown
- 2004-04-01 JP JP2006504952A patent/JP2006522054A/ja active Pending
- 2004-04-01 WO PCT/EP2004/003478 patent/WO2004087133A1/en not_active Ceased
- 2004-04-01 KR KR1020057018676A patent/KR20060002915A/ko not_active Ceased
- 2004-04-01 CL CL200400705A patent/CL2004000705A1/es unknown
- 2004-04-01 EP EP04725014A patent/EP1613305A1/en not_active Ceased
- 2004-04-01 RU RU2005133660/04A patent/RU2005133660A/ru not_active Application Discontinuation
- 2004-04-01 NZ NZ542432A patent/NZ542432A/en unknown
- 2004-04-01 CA CA002520682A patent/CA2520682A1/en not_active Abandoned
- 2004-04-01 US US10/550,631 patent/US20070135353A1/en not_active Abandoned
- 2004-04-01 BR BRPI0409009-8A patent/BRPI0409009A/pt not_active IP Right Cessation
-
2005
- 2005-09-07 ZA ZA200507179A patent/ZA200507179B/en unknown
- 2005-09-28 EC EC2005006043A patent/ECSP056043A/es unknown
- 2005-09-30 TN TNP2005000248A patent/TNSN05248A1/en unknown
- 2005-10-04 CO CO05100510A patent/CO5630028A2/es not_active Application Discontinuation
- 2005-10-11 MA MA28547A patent/MA27763A1/fr unknown
- 2005-10-27 IS IS8093A patent/IS8093A/is unknown
- 2005-11-01 NO NO20055097A patent/NO20055097L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20055097L (no) | 2005-12-22 |
| CA2520682A1 (en) | 2004-10-14 |
| US20070135353A1 (en) | 2007-06-14 |
| RU2005133660A (ru) | 2006-06-10 |
| AU2004226815B2 (en) | 2007-07-19 |
| NZ542432A (en) | 2009-04-30 |
| PE20050392A1 (es) | 2005-06-19 |
| TNSN05248A1 (en) | 2007-06-11 |
| MXPA05010610A (es) | 2005-11-23 |
| BRPI0409009A (pt) | 2006-03-28 |
| IS8093A (is) | 2005-10-27 |
| AU2004226815A1 (en) | 2004-10-14 |
| CO5630028A2 (es) | 2006-04-28 |
| SG166681A1 (en) | 2010-12-29 |
| CL2004000705A1 (es) | 2005-01-14 |
| WO2004087133A1 (en) | 2004-10-14 |
| MY136854A (en) | 2008-11-28 |
| ZA200507179B (en) | 2006-04-26 |
| NO20055097D0 (no) | 2005-11-01 |
| KR20060002915A (ko) | 2006-01-09 |
| ECSP056043A (es) | 2006-01-27 |
| JP2006522054A (ja) | 2006-09-28 |
| TW200427458A (en) | 2004-12-16 |
| EP1613305A1 (en) | 2006-01-11 |
| AR043804A1 (es) | 2005-08-10 |
| CN1764450A (zh) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27946A1 (fr) | Omega-carboxyaryldiphenyluree fluoro-substituee pour le traitement et la prevention de maladies et d'etats pathologiques. | |
| MA27643A1 (fr) | Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens | |
| IL171977A0 (en) | Cyclic sulfonamides for inhibition of gamma-secretase | |
| BR0014470A (pt) | Inibidores de fab i | |
| MEP24608A (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
| DE602004007808D1 (de) | Neue gamma secretase inhibitoren | |
| NO20024424D0 (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene | |
| GB0225475D0 (en) | Therapeutic agents | |
| NO20053246L (no) | Kondensert 1,3-dihydroimidazol-ringforbindelse. | |
| TNSN04164A1 (fr) | Inhibiteurs de acc. | |
| ATE464287T1 (de) | Cyclohexyl-sulphone als gamma-sekretase- inhibitoren | |
| MA27774A1 (fr) | Inhibiteurs de phosphatidylinositol 3-kinase | |
| SE9904108D0 (sv) | Nya föreningar | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| MA27763A1 (fr) | Composes n-formyl-hydroxylamine cristallins | |
| SE0101082D0 (sv) | Novel use | |
| MA27549A1 (fr) | N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones | |
| SE0300705D0 (sv) | New compounds | |
| MXPA02011553A (es) | N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino. | |
| DK1541553T3 (da) | Indolinforbindelse samt medicinsk anvendelse deraf | |
| TH70058A (th) | อนุพันธ์ 2, 3 -ไดแอริล-ไพราโซลิดีนชนิดใหม่ที่เป็นตัวยับยั้งเอนไซม์ที่ทำให้นิวโรเทนซินเสื่อมสลาย | |
| ZA882775B (en) | Pharmaceutical use of organic compounds | |
| TW200505836A (en) | Cyclic sulfonamides for inhibition of gamma-secretase | |
| MA29934B1 (fr) | Traitement des symptomes de l'irritation vesicale | |
| TH60570A3 (th) | ตัวกระทำไอโซซาโซลิโนนชนิดใหม่ที่มีฤทธิ์ในการต่อต้านแบคทีเรีย |